fda ruling on tirzepatide today Drugmakers can keep making off-brand weight-loss drugs as backpedals FDA Says Compounded Tirzepatide Must

Most patients will return to their original weight less than two years after stopping weight-loss medication, regaining an average of 0.4 kilograms a month, according to a new analysis

However, if you maintain or continue your weight loss efforts, those facial changes will remain

We recommend taking 0.1ml (a tenth of your syringe) each night before bed

At least that is what I think, I may be wrong though

Microdosed tirzepatide is described by the brand as tirzepatide at a lower, sub-therapeutic dose

This safety profile contrasts sharply with full growth hormone, which carries risks of diabetes development, acromegaly (abnormal tissue growth), increased cancer risk, hypertension, and other systemic effects